aBstrac t objective Accurate biomarkers of the acute respiratory distress syndrome (ARDS) may help risk stratification and management. We assessed the relation between several biomarkers and the severity, course and outcome of late onset ARDS in 101 consecutive critically ill patients with new onset fever.
methods On study days 0, 1, 2 and 7 we measured angiopoietin-2 (ANG2), pentraxin-3, interleukin-6 (IL6), procalcitonin (PCT), and midregional pro-adrenomedullin (proADM). ARDS was defined by the Berlin definition and by the lung injury score (LIS).
results At baseline, 48% had ARDS according to the Berlin definition and 86% according to the LIS. Baseline markers poorly predicted maximum Berlin categories attained within 7 days, whereas ANG2 best predicted maximum LIS. Depending on the ARDS definition, the day-by-day area under the receiver operating characteristic curves suggested greatest monitoring value for IL6 and PCT, followed by ANG2. ANG2 and proADM predicted outcome, independently of disease severity.
conclusions Whereas IL6 and PCT had some disease monitoring value, ANG2 was the only biomarker capable of both predicting the severity, monitoring the course and predicting the outcome of late onset ARDS in febrile critically ill patients, irrespective of underlying risk factor, thereby yielding the most specific ARDS biomarker among those studied.
introd uction
The acute respiratory distress syndrome (ARDS) following sepsis, trauma, pancreatitis and other insults is caused by alveolocapillary inflammation and increased permeability and is frequently underdiagnosed, particularly when developing late (≥48 hours) in the intensive care unit (ICU). [1] [2] [3] Many underlying conditions of ARDS are associated with fever, such as sepsis, and fever itself may also aggravate alveolocapillary inflammation 4 ; fever therefore denotes a risk factor. There are various clinical classification systems for ARDS, including the recent Berlin definition and the old, more elaborate 
Berlin definition of ARDS

6
Preconditions:
Timing Onset within 1 week of a known clinical insult or worsening of respiratory symptoms.
Imaging
Bilateral opacities on chest radiograph or computed tomography not fully explained by effusions, lobar/lung collapse, or nodules.
Origin of oedema Respiratory failure not fully explained by cardiac failure of fluid overload (Need objective assessment to exclude hydrostatic oedema if no risk factor present (e.g. echocardiography). The final lung injury score is obtained by calculating the average of all four categories.
No lung injury ≤1 mild ARDS 1-2.5 severe ARDS >2.5
Abbreviations: ARDS-acute respiratory distress syndrome, PaO2/FiO2 -arterial O2 pressure over inspiratory O2 fraction, PEEP-positive end-expiratory pressure; pulmonary compliance = (tidal volume / (peak inspiratory pressure -PEEP).
lung injury score (LIS , Table 1 ). 1, [5] [6] [7] Although used as a clinical standard for diagnosis, the limitation of the Berlin definition is its dependency on ventilator treatment (with positive end-expiratory pressure affecting the oxygenation ratio and chest radiography in mechanically ventilated patients) and lack of a specific index of severity such as the total respiratory compliance, that is incorporated in the LIS. [5] [6] [7] [8] The LIS score, however, does not include bilateral consolidations as a criterion. The LIS may therefore constitute a more refined but complex and not routine measure of the clinical severity of ARDS correlating with alveolocapillary permeability. 1, 9 Nevertheless, the agreement of both classification systems with diffuse alveolar damage at autopsy is limited 1, 10, 11 and apart from the laborious direct measurement of alveolocapillary permeability, if available, 9 there is no in vivo reference standard for diagnostics and monitoring. 12 Moreover, two phenotypes of ARDS may prevail: one with hyperinflammatory sepsis, shock and a poor outcome and the other without such abnormalities. 13 Because of clinical classification problems, amongst others, there is an active search for biomarkers that may accurately predict the development or presence of alveolocapillary inflammation of ARDS and would help in risk stratification and management in future studies. [14] [15] [16] We and others previously described that circulating angiopoietin-2, possibly derived from the pulmonary vessel wall, is associated with alveolocapillary permeability, development of clinical ARDS, positive fluid balance and mortality in the critically ill sepsis or trauma patients, even though sepsis and trauma may predispose to different ARDS phenotypes. 12, 13, 16, [17] [18] [19] [20] [21] [22] [23] [24] The biomarker value for ARDS of alternative molecules such as pentraxin-3, a pro-inflammatory acute phase mediator, [25] [26] [27] interleukin-6, a cytokine with both pro-and anti-inflammatory properties, [14] [15] [16] 19, 25, [28] [29] [30] [31] [32] [33] procalcitonin, a marker of inflammation, 15, 16, 34, 35 and midregional pro-adrenomedullin, a stable fragment of adrenomedullin with immune modulating, metabolic and vasodilator actions and prognostic properties in pneumonia and sepsis, [36] [37] [38] [39] remains unclear up till now.
The literature on foregoing biomarkers reported on less than 60 patients 13, 17, 20, 26, 28, 32, 35 or on only one single marker or clinical classification system for ARDS. 14, 15, [17] [18] [19] [20] [21] [22] [23] [24] 26, 28, [31] [32] [33] [34] [35] Moreover, many studies were cross-sectional. 11, 12, 14, 15, [17] [18] [19] 21, 23, 24, [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] Since these studies focused mostly on early ARDS development or its outcome, the value of biomarkers in reflecting severity and course of late onset ARDS regardless of risk factors is largely unknown. Therefore, the goal of the present, longitudinal study was to investigate which biomarker would be most accurate in predicting and monitoring the severity, course and outcome of ARDS in critically ill patients after new onset fever who are at risk for the syndrome. The hypothesis was that biomarkers directly associated with inflammation, such as angiopoietin-2, interleukin-6 and procalcitonin would be more accurate than those indirectly associated with inflammation, such as pentraxin-3 and proadrenomedullin, independent of underlying ARDS risk factor. 13, 15, 16, 18, 29 
patie nts and methods
This was a prospective observational study on the accuracy of biomarkers to predict and monitor ARDS severity in critically ill patients with new onset fever. This study was ancillary to the original one evaluating the role of biomarkers to predict infection and resultant organ failure. 40 The original study was approved by the VU University 
study p r o to c o l
Day 0 (baseline) was the day of new onset fever. Demographic variables, potential ARDS risk factor on ICU admission and baseline characteristics were recorded within 12 hours of presenting new onset fever. To express disease severity, we used the simplified acute physiology score (SAPS) II on admission and the sequential organ failure assessment (SOFA) score on study days. In addition to clinical and radiological assessment, the central venous pressure (CVP, mmHg), which was routinely measured in 83% of patients, was registered to exclude severe fluid overload and severe heart failure. On study days 0, 1, 2, and 7 respiratory parameters, chest radiographs, and blood samples for biomarker measurement were collected.
definit ion s
The Berlin definition and LIS were used to diagnose ARDS and classify ARDS severity on study days. We reviewed all chest radiographs collected on study days unaware of biomarker results and attempted to exclude gross overhydration or signs of congestive heart failure in classifying alveolar consolidations, heart size, vascular pedicle, sence of a hydrostatic cause. 6 In contrast, the LIS consists of 3 categories that reflect ARDS severity: no lung injury/ARDS (LIS ≤1), mild (LIS 1-2.5) and severe ARDS (LIS >2.5). 5 The ratio incorporates the P a O 2 /F I O 2 ratio, the PEEP, total respiratory dynamic compliance and number of quadrants with alveolar consolidations on chest radiography, in the presence of a known clinical etiology. Compliance is calculated from plateau inspiratory pressure-PEEP/tidal volume, in pressure-guided mechanically ventilated patients. In addition, the maximum Berlin category and maximum LIS during the 7-day course were registered. We used the lowest P a O 2 /F I O 2 ratio per day and corresponding PEEP levels and compliance. Sepsis was defined according to American Society of Chest Physicians/ Society of Crit Care Med criteria 41 as the presence of either clinically suspected or proven infection and the systemic inflammatory response syndrome. We considered the day of specimen collection and/or imaging the day of diagnosis when results were positive. Shock was diagnosed when the systolic arterial pressure was <90 mmHg or the mean arterial pressure (MAP) was <65 mmHg for ≥1 hour in spite of adequate fluid resuscitation and/or need of vasopressor administration. 42 Septic shock was the presence of sepsis and shock. Mortality is 28-day mortality.
Biomar k e r a s s a y t e s t s p e c i f i c s
Angiopoietin 2 (ANG2) and pentraxin 3 (PTX3) were measured using the Quantikine Enzyme-Linked Immunosorbent Assay (ELISA) Kit (R&D systems Inc. Minneapolis, United States). Test specifics for ANG2: lower detection limit 0.05 ng/mL, upper detection limit 3 ng/mL, normal value in healthy subjects around 0.1 ng/mL with an upper limit of 1.2 ng/mL [7, 12] . The intra-assay coefficient of variation (CV) is 6.5% and inter-assay CV 10%, while the average recovery in serum is 100%. Test specifics for PTX3: lower detection limit 0.31 ng/mL, upper detection limit 20 ng/mL with an upper limit in healthy subjects <2 ng/mL. The intra-assay CV is <4.5% and inter-assay CV 6%, with average recovery in serum of 99%. Interleukin-6 (IL6) was measured using the Luminex performance Assay Fluorokine MAP (R&D systems Inc. Minneapolis, United States): lower detection limit 0.36 pg/mL, normal value of IL6 in healthy subjects around 1 pg/mL, intra-assay CV <5%, inter-assay CV <9%, and average recovery in serum 108%. Procalcitonin (PCT) and midregional pro-adrenomedullin (proADM) were measured using the Kryptor compact system (Brahms Diagnostica, Henningsdorf, Germany). For PCT: lower detection limit 0.02 ng/mL, upper limit in healthy subjects 0.05 ng/mL, and intra-assay and inter-assay CV <6%. Test specifics of pro-adrenomedullin (proADM): lower detection limit 0.05 nmol/L, upper limit in healthy subjects 0.55 nmol/L, intra-assay CV <4% and inter-assay CV <11%.
statistic a l a n a l y s i s from the optimal Youden's index (J= sensitivity + specificity-1; were J=1 represents perfect diagnostic test accuracy). 43 To study the predictive value and interdependency of baseline biomarker levels, sepsis and SAPS II for 28-day mortality multivariate logistic regression was performed, with the Hosmer-Lemeshow test for goodness of fit, using stepwise backward elimination of predictors based on the likelihood ratio.
Two sided P-values <0.05 were considered statistically significant unless specified otherwise; P-values are exact unless P<0.001. To correct for multiple testing only P-values ≤0.01 were considered statistically significant in the tables with AUROC's.
results patien t c h a r a c t e r i s ti c s
According to the Berlin definition, 53% had no ARDS (Berlin 0) at baseline, 9% mild patients a potential ARDS risk factor was present on ICU documented and occasionally patients suffered two or more potential risk factors (Table 2) . Forty-two patients never met the Berlin and 6 never the LIS definition of ARDS in the course of the study and severity in the other patients varied over time. In 30 and 26%, respectively, patients reached their maximum Berlin AND LIS category after day 0. Relatively low baseline CVP suggests that absence of overhydration.
Baseli n e b iom a r k e r l e v e l s a n d m a xi mu m A R DS sev e ri ty wi th in 7
days
Only baseline PTX3 (P=0.03) and IL6 (P=0.04) differed across maximum Berlin categories, while baseline ANG2 (P=0.007), IL6 (P=0.02), and PCT (P=0.007) differed across maximum LIS categories (Table 3) . However, in the sensitivity analysis the biomarker concentrations differed mainly at low Berlin and high LIS categories.
Baseline ANG2 predicted maximum ARDS severity according to LIS (Table 4) . Other biomarkers' predictive values were poor.
day-by -d a y b i om a r k e r l e v e l s f or m on itor in g a r ds
The following associations were independent of including sepsis as a factor. The ANG2
and PCT levels were directly associated with Berlin and LIS categories, throughout the 7-day course ( Fig .1 and 2 ). IL6 and ProADM levels had a direct association with LIS only. The day-by-day AUROC's (Table 5 ) suggested greatest monitoring value for IL6
and PCT, followed by ANG2 and then by proADM, depending on the ARDS definition.
mortalit y
Mortality of patients with maximum Berlin categories increased from 12% (Berlin 0) to 33 % (Berlin 1), 31% (Berlin 2) and 55% (Berlin 3, P=0.02). For maximum LIS category, mortality increased from 0 (LIS ≤1) to 24% (LIS 1-2.5) and 32% (LIS >2.5 P=0.27). Baseline values of ANG2, PCT, IL6 and proADM were higher in 28-day nonsurvivors than in survivors (Table 6 ). Mortality prediction was investigated in the entire cohort and in the subgroups of ARDS according to the Berlin criteria or the LIS score.
In the entire cohort, multiple logistic regression showed that baseline ANG2 (P=0.001, Median (interquartile range), P-Mann Whitney U test. Abbreviations: ANG2-angiopoietin 2, ARDS-acute respiratory distress syndrome, IL6-interleukin 6, LIS-lung injury score, maxmaximum ARDS severity within 7 days of new onset fever, PCT-procalcitonin, PTX3-Pentraxin 3, proADM-midregional pro-adrenomedullin To correct for multiple testing an adjusted P-value ≤0.01 was considered statistically significant. Abbreviations: ANG2-angiopoietin 2, ARDS-acute respiratory distress syndrome, AUC-area under the receiver operating characteristics curve, IL6-interleukin 6, LIS-lung injury score, NPVnegative predictive value, PCT-procalcitonin, PPV-positive predictive value, PTX3-pentraxin 3-proADM-midregional pro-adrenomedullin, SN-sensitivity, SP-specificity. proADM (P<0.001) were higher in non-survivors (Fig. 3) . In patients with a maximum Berlin ≥1 or maximum LIS category >1, ANG2 and proADM at baseline were higher in non-survivors than survivors (Table 6 ). In patients with a maximum Berlin ≥1, multiple logistic regression showed that baseline ANG2 (P=0.02, Hosmer-Lemeshow To correct for multiple testing an adjusted P-value ≤0.01 was considered statistically significant. Abbreviations: ANG2-angiopoietin-2, ARDS-acute respiratory distress syndrome, AUC-area under the receiver operating characteristics curve, IL6-interleukin-6, LIS-lung injury score, NPV-negative predictive value, max-maximum ARDS severity within 7 days of new onset fever, PCT-procalcitonin, PPV-positive predictive value, PTX3-pentraxin-3-proADM-midregional proadrenomedullin, SN-sensitivity, SP-specificity. In critically ill patients with new-onset fever, LIS category over one week is directly related with the levels of ANG2 (P=0.03), IL6 (P<0.001), PCT (P<0.001) and proADM (P<0.001), independent of sepsis (P= 0.06, 0.25, 0.50 and 0.56, respectively), in generalized estimating equations.
• no ARDS, ■ mild ARDS, ▲ severe ARDS. Abbreviations: ARDS-acute respiratory distress syndrome, ANG2-angiopoietin-2, LIS-lung injury score, PTX3-pentraxin-3, IL6-Interleukin-6, PCT-procalcitonin, proADM-midregional pro-adrenomedullin. 
discussion
In this longitudinal study in critically ill patients with or at risk for late ARDS after new onset fever, ANG2 was of value in predicting the maximum severity, monitoring the course and predicting the outcome of the syndrome, whereas IL6 and PCT had value for daily monitoring of severity, irrespective of underlying risk factor. ProADM only Median (interquartile range). Abbreviations: ANG2-angiopoietin-2, ARDS-acute respiratory distress syndrome, proADM-midregional pro-adrenomedullin, IL6-interleukin-6, LIS-lung injury score, PCT-procalcitonin, PTX3-pentraxin-3.
predicted 28-day mortality, independent of the SAPS II score. The data suggest ANG2
as the most specific ARDS biomarker, among those studied.
To the best of our knowledge, this is the first longitudinal study relating a panel of biomarkers to both Berlin and LIS-defined, late onset ARDS in the ICU. The differences between the classification systems may explain why the monitoring ability of biomarker levels better correlated with LIS than Berlin definitions. The Berlin definition requires bilateral radiographic consolidations and the severity of ARDS in the Berlin definition is expressed by gas exchange only, which is dependent of ventilator settings.
Its focus is, therefore, more on diagnosis of ARDS than on monitoring of its severity. 7, 8 In contrast, the LIS includes radiographic criteria, gas exchange, level of PEEP and compliance. As such, the LIS may better represent severity of lung injury than the Berlin definition, but carries the risk of oversensitivity and thus overestimation of the syndrome, since more patients may not have ARDS according to Berlin than LIS categories, as indicated by our current and previous studies. 2, 8 Conversely, relatively low ANG2 levels already predicted a maximum LIS >1, but this association at low disease severity may be clinically less useful than those at high disease severity. Indeed, the optimal cutoffs using the Youden index 43 resulted in higher positive predictive values with less disease severity and higher negative predictive values with greater disease severity. We used both overlapping clinical systems to evaluate the uniform clinical value of biomarkers in the absence of a true reference standard, even though they may not accurately predict diffuse alveolar damage at autopsy. 1, 10, 11 In any case, the mortality of our ARDS patients that somewhat increased with increasing severity roughly agrees with the literature. 3, 7, [12] [13] [14] 16, 19, 20, 28, 29 Of note, mortality increased across Berlin categories while the increase did not reach statistical significance for increasing LIS categories, possibly because of underpowering.
Even though the baseline predictive values of biomarkers for maximum Berlin and LIS categories within the study week were relatively poor, the day-to-day diagnostic value for severity and thus the monitoring value of these biomarkers were greater. This particularly applies to IL6, PCT and ANG2, irrespective of ARDS definitions. Indeed, alveolocapillary inflammation and increased vascular permeability with non-cardiogenic edema is the hallmark of ARDS, and ANG2 may be directly involved. 12 14, 15, [28] [29] [30] [31] The value and limitations of IL6 to diagnose and monitor ARDS severity, resulting from community-acquired pneumonia, for instance, have been described before. 14, 24, 30, 32, 33 For PCT, we found no study to document its monitoring value for ARDS even though it may predict early ARDS development in community acquired pneumonia and a poor outcome. 34, 35, 37 In contrast, another study found no relation between PCT levels and mortality in ARDS, 15 in line with our results.
PTX3 behaves like an acute phase protein, is a marker of innate immunity and inflammation, and may have a role in the complement-mediated clearance of apoptotic cells. 25 PTX3 overexpression has been found in severe infections, mechanical ventilation and other risk factors for ARDS. 25, 26, 27 Unlike previous reports, 26, 27 PTX3 in our study was poorly associated with ARDS severity and non-survival. Of note, our PTX3 levels were relatively low as compared to those in previous studies on sepsis and ARDS, which may relate to differences in patient mix. 26, 27 As part of the calcitonin-gene family such as PCT, proADM levels rise during severe infections and inflammation and this has been associated with disease severity in pneumonia and sepsis in previous studies. [36] [37] [38] [39] ProADM had fair predictive value for maximum ARDS severity and non-survival and correlated to LIS but not to Berlin categories throughout the 7-day course. In multiple logistic regression, proADM predicted 28-day mortality, independently from SAPS II. To our best knowledge, this is the first study evaluating the value of proADM in predicting and monitor ARDS severity, which appeared limited.
The study has several limitations including moderate size and heterogeneity of the study population. We used fever as the inclusion criterion to define a general symptom of conditions that would predispose patients to late onset ARDS in the ICU. 3 Moreover, fever may augment alveolocapillary inflammation. 4 . Potentially resultant patient heterogeneity can also be regarded as a factor favoring generalizability of results, which would have been less if a more specific condition as entry criterion had been chosen.
We reviewed clinical symptoms, history, and the chest radiographs in combination with CVP levels in an attempt to exclude gross overhydration or congestive heart failure in classifying alveolar consolidations. However, we cannot fully exclude a cardiogenic component of edema in some of these ARDS patients. We also focused on the course of ARDS rather than its development since the study goal was to find biomarkers of value in predicting severity and monitoring of late onset ARDS rather than prediction of the development of the syndrome. In line with recent research that ARDS phenotypes may differ according to sepsis as an etiologic factor, 13 we examined the contribution of this factor to the associations reported, as done before, 15, 29 which appeared negligible. The value of many biomarkers in our study was nevertheless imperfect with some AUROC <0.70, allowing future studies in search of better ARDS biomarkers. Nevertheless, the availability of rapid measurements could facilitate future studies on stratifying risks and monitoring treatment of ARDS by ANG2 for instance.
conclusions
In conclusion, ANG2 was the only biomarker capable of both predicting the severity, monitoring the course, and predicting the outcome of late onset ARDS in febrile critically ill patients, irrespective of underlying risk factor, thereby yielding the most specific ARDS biomarker among those studied. In contrast to IL6 and PCT which had some disease monitoring value only.
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